StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)

Investment analysts at StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Price Performance Can-Fite BioPharma stock opened at $2.09 on Tuesday. Can-Fite BioPharma has a one year low of $1.76 and […]

Related Keywords

Fite Biopharma ,Schechter Investment Advisors ,Exchange Commission ,Fite Biopharma Ltd ,Fite Biopharma Company Profile ,Can Fite Biopharma ,Get Free Report ,Investment Advisors ,Free Report ,Can Fite Biopharma Daily ,Nyse Canf ,Ocanf ,Medical ,Initiated Coverage ,Stocknews Com ,